[1]ÍõÑÒ,ÕÅ°®Ï¼,Íõ×ÏêÍ,µÈ.¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó¡¢ÑªÇåºÍÌÇƤÖʼ¤ËØÓÕµ¼µÄµ°°×¼¤Ã¸3±í´ïÓëѪҺ͸Îö»¼Õ߶¯¾²ÂöÄÚðüʧ¹¦µÄ¹Øϵ[J].ÐÂÏçҽѧԺѧ±¨,2023,40(9):851-855.[doi:10.7683/xxyxyxb.2023.09.009]
¡¡WANG Yan,ZHANG Aixia,WANG Zihui,et al.Relationship between the expression of basic fibroblast growth factor,serum and glucocorticoid-induced protein kinase 3 and the dysfunction of arteriovenous fistula in patients undergoing hemodialysis[J].Journal of Xinxiang Medical University,2023,40(9):851-855.[doi:10.7683/xxyxyxb.2023.09.009]
µã»÷¸´ÖÆ

¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó¡¢ÑªÇåºÍÌÇƤÖʼ¤ËØÓÕµ¼µÄµ°°×¼¤Ã¸3±í´ïÓëѪҺ͸Îö»¼Õ߶¯¾²ÂöÄÚðüʧ¹¦µÄ¹Øϵ
·ÖÏíµ½£º

¡¶ÐÂÏçҽѧԺѧ±¨¡·[ISSN:1004-7239/CN:41-1186/R]

¾í:
40¾í
ÆÚÊý:
2023Äê9
Ò³Âë:
851-855
À¸Ä¿:
ÁÙ´²Ñо¿
³ö°æÈÕÆÚ:
2023-09-05

ÎÄÕÂÐÅÏ¢/Info

Title:
Relationship between the expression of basic fibroblast growth factor,serum and glucocorticoid-induced protein kinase 3 and the dysfunction of arteriovenous fistula in patients undergoing hemodialysis
×÷Õß:
ÍõÑÒÕÅ°®Ï¼Íõ×ÏêÍÍõÇ«ÊÜ
£¨ÂåÑôÊж«·½ÈËÃñҽԺѪҺ¾»»¯¿Æ£¬ºÓÄÏ¡¡ÂåÑô¡¡471003£©
Author(s):
WANG YanZHANG AixiaWANG ZihuiWANG Qianshou
£¨Department of Blood Purification£¬Luoyang Dongfang People¡äs Hospital£¬Luoyang 471003£¬Henan Province£¬China£©
¹Ø¼ü´Ê:
¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×ÓѪÇåºÍÌÇƤÖʼ¤ËØÓÕµ¼µÄµ°°×¼¤Ã¸3ѪҺ͸Îö¶¯¾²ÂöÄÚðü
Keywords:
basic fibroblast growth factorserum and glucocorticoid-induced protein kinase 3hemodialysisarteriovenous fistulas
·ÖÀàºÅ:
R459.5
DOI:
10.7683/xxyxyxb.2023.09.009
ÎÄÏ×±êÖ¾Âë:
A
ÕªÒª:
Ä¿µÄ¡¡Ì½ÌÖ¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó£¨b-FGF£©¡¢ÑªÇåºÍÌÇƤÖʼ¤ËØÓÕµ¼µÄµ°°×¼¤Ã¸3£¨SGK3£©±í´ïÓëѪҺ͸Îö£¨HD£©»¼Õ߶¯¾²ÂöÄÚðü£¨AVF£©Ê§¹¦µÄ¹Øϵ¡£
·½·¨¡¡Ñ¡Ôñ2019Äê1ÔÂÖÁ2021Äê12ÔÂÔÚÂåÑôÊж«·½ÈËÃñÒ½Ôº½ÓÊÜHDµÄ80Àý»¼ÕßΪÑо¿¶ÔÏ󣨹۲ì×飩£¬ÁíÑ¡ÔñͬÆÚÈëÔºÌå¼ì½¡¿µÕß30Àý×÷Ϊ¶ÔÕÕ×é¡£¸ù¾ÝÊÇ·ñ°éÓÐAVFʧ¹¦½«¹Û²ì×黼Õß·ÖΪAVFʧ¹¦×飨n=31£©ºÍAVFδʧ¹¦×飨n=49£©¡£²ÉÓÃøÁªÃâÒßÎü¸½·¨¼ì²âËùÓÐÊÜÊÔÕßѪÇåÖÐb-FGFˮƽ£¬²ÉÓÃÃâÒß×éÖ¯»¯Ñ§·¨¼ì²âѪÇåÖÐSGK3ˮƽ£»²¢±È½Ï¹Û²ì×éºÍ¶ÔÕÕ×éÊÜÊÔÕßѪÇåÖÐb-FGF¡¢SGK3ˮƽ¡£ÊÕ¼¯¹Û²ì×黼ÕßµÄÁÙ´²×ÊÁÏ£¬²ÉÓõ¥ÒòËغͶàÒòËØlogsitic»Ø¹é·ÖÎöHD»¼Õß·¢ÉúAVFʧ¹¦µÄΣÏÕÒòËØ£¬²¢Öصã¹Û²ìѪÇåb-FGF¡¢SGK3ˮƽÓëHD »¼ÕßAVFʧ¹¦µÄ¹Øϵ¡£»æÖÆÊÜÊÔÕß²Ù×÷ÌØÕ÷£¨ROC£©ÇúÏßÆÀ¹Àb-FGF¡¢SGK3¶ÔHD »¼Õß·¢ÉúAVFʧ¹¦µÄÔ¤²â¼ÛÖµ¡£
½á¹û¡¡¹Û²ì×黼ÕßѪÇåÖÐb-FGF¡¢SGK3ˮƽÏÔÖø¸ßÓÚ¶ÔÕÕ×飨P<0.05£©¡£µ¥ÒòËØ·ÖÎö½á¹ûÏÔʾ£¬AVFʧ¹¦×éÓëAVFδʧ¹¦×黼ÕßµÄÄêÁ䡢͸Îöʱ¼ä¡¢Í¸ÎöƵÂÊ¡¢°×ϸ°û£¨WBC£©¼ÆÊý¡¢ÑªÏ¸°û±ÈÈÝ£¨Hct£©¡¢ÖÐÐÔÁ£Ï¸°û/ÁÜ°Íϸ°û±ÈÖµ£¨NLR£©¡¢ÑªÐ¡°å/ÁÜ°Íϸ°û±ÈÖµ£¨PLR£©¡¢ÑªÐ¡°å£¨PLT£©¼ÆÊý¼°b-FGF¡¢SGK3¡¢¿Õ¸¹ÑªÌÇ£¨FPG£©¡¢¼¡¸Æµ°°×T£¨TnT£©¡¢½µ¸ÆËØÔ­£¨PCT£©¡¢ÑªÄòËᣨUA£©¡¢¸ßÃܶÈÖ¬µ°°×£¨HDL£©Ë®Æ½ºÍÌÇÄò²¡Ê·¡¢³éÑÌÊ·Õ¼±È±È½Ï²îÒìÓÐͳ¼ÆѧÒâÒ壨P<0.05£©£»logistic»Ø¹é·ÖÎö½á¹ûÏÔʾ£¬¸ßb-FGF¡¢SGK3¡¢NLR¡¢PLRˮƽ¼°Í¸ÎöƵÂʺͳ¤Ê±¼ä͸ÎöÊÇHD»¼Õß·¢ÉúAVFʧ¹¦µÄ¶ÀÁ¢Î£ÏÕÒòËØ£¨P<0.05£©¡£ROCÇúÏß·ÖÎö½á¹ûÏÔʾ£¬ÑªÇåb-FGFÔ¤²âHD»¼Õß·¢ÉúAVFʧ¹¦µÄÁéÃô¶È¡¢ÌØÒì¶È·Ö±ðΪ85.96%¡¢69.57%£¬ÑªÇåSGK3Ô¤²âHD»¼Õß·¢ÉúAVFʧ¹¦µÄÁéÃô¶È¡¢ÌØÒì¶È·Ö±ðΪ 87.72%¡¢73.91%£»¶þÕßÁªºÏ¼ì²âÔ¤²âHD»¼Õß·¢ÉúAVFʧ¹¦µÄÁéÃô¶È¡¢ÌØÒì¶È·Ö±ðΪ91.53%¡¢85.71%¡£
½áÂÛ¡¡HDµ¼ÖÂAVFʧ¹¦»¼ÕßѪÇåÖÐb-FGF¡¢SGK3ˮƽÉý¸ß£¬¶þÕßÁªºÏ¼ì²â¶ÔHD»¼Õß·¢ÉúAVFʧ¹¦¾ßÓнϸߵÄÔ¤²âЧÄÜ£¬¿É½«Æä×÷ΪԤ²âHD»¼Õß AVFʧ¹¦µÄÓÐЧÒò×Ó£¬ÎªÁÙ´²Ô¤·À¡¢ÓÅ»¯ÖÎÁÆ´ëÊ©Ìṩ°ïÖú¡£
Abstract:
Objective¡¡To investigate the relationship between the expression of basic fibroblast growth factor (b-FGF),serum and glucocorticoid-induced protein kinase 3 (SGK3) and the dysfunction of autogenous arteriovenous fistulas (AVF) in hemodialysis (HD) patients.
Methods¡¡A total of 80 patients who received HD in Luoyang Dongfang People¡äs Hospital from January 2019 to December 2021 were selected as the study subjects (observation group),and 30 healthy individuals who underwent physical examination during the same period were selected as the control group.The patients in the observation group were divided into AVF dysfunction group (n=31) and AVF non-dysfunction group (n=49) according to whether they were accompanied with AVF dysfunction.The serum b-FGF level of all subjects was detected by enzyme linked immunosorbent assay,the serum SGK3 level of all subjects was detected by immunohistochemistry;and the serum b-FGF,SGK3 levels of all subjects were compared between the observation group and the control group.The clinical data of patients in the observation group were collected,and the risk factors of AVF dysfunction in HD patients were analyzed by univariate and multifactorial logsitic regression,and the relationship between serum b-FGF,SGK3 levels and AVF dysfunction in HD patients was mainly observed.Receiver operating characteristic (ROC) curve was drawed to evaluate the predictive value of b-FGF and SGK3 for AVF dysfunction in HD patients.
Results¡¡The serum levels of b-FGF and SGK3 of patients in the observation group were significantly higher than those in the control group (P<0.05).The results of univariate analysis showed that there was significant difference in the age,dialysis time,dialysis frequency,white blood cell (WBC) count,hematocellular volume (Hct),neutrophil/lymphocyte ratio (NLR),platelet/lymphocyte ratio (PLR),platelet (PLT) count and b-FGF,SGK3,fasting blood glucose (FPG),troponin T (TnT),procalcitonin (PCT),blood uric acid (UA),high-density lipoprotein (HDL) levels and the proportion of diabetes history and smoking history of patients between the AVF dysfunction group and AVF non-dysfunction group (P<0.05).Logistic regression analysis showed that high b-FGF,SGK3,NLR,PLR levels,dialysis frequency and long dialysis time were independent risk factors for AVF dysfunction in HD patients(P<0.05).ROC curve analysis results showed that the sensitivity and specificity of serum b-FGF in predicting AVF dysfunction in HD patients were 85.96% and 69.57%,respectively and the sensitivity and specificity of serum SGK3 in predicting AVF dysfunction in HD patients were 87.72% and 73.91%,respectively;the sensitivity and specificity of the combined detection of b-FGF and SGK3 in predicting AVF dysfunction in HD patients were 91.53% and 85.71%,respectively.
Conclusion¡¡Serum levels of b-FGF and SGK3 in patients with AVF dysfunction after HD are increased,and the combined detection of the two indexes has high predictive efficacy for AVF dysfunction in HD patients,which could be used as an effective factor to predict AVF dysfunction in HD patients,and provide help for clinical prevention and optimization of treatment measures.

²Î¿¼ÎÄÏ×/References:

£Û1£Ý¡¡ÍõÑÒ,ÕÅ°®Ï¼,Íõ×ÏêÍ,µÈ.¸ßͨÁ¿ÑªÒºÍ¸ÎöÓëÁª»úѪҺ͸ÎöÂ˹ýÁªºÏÖÎÁÆÂýÐÔÉöË¥½ßÁÆЧ¹Û²ì£ÛJ£Ý.ÐÂÏçҽѧԺѧ±¨,2022,39(6):573-577.
WANG Y,ZHANG A X,WANG Z H,et al.Curative effect of high-flux hemodialysis combined with online hemodiafiltration in the treatment of chronic renal failure£ÛJ£Ý.J Xinxiang Med Univ,2022,39(6):573-577.
£Û2£Ý¡¡PIRYANI A K,KILARI S,TAKAHASHI E,et al.Rationale and trial design of mesenchymal stem cell trial in preventing venous stenosis of hemodialysis vascular access arteriovenous fistula (MEST AVF Trial)£ÛJ£Ý.Kidney 360,2021,2(12):1945-1952.
£Û3£Ý¡¡LI Y,CUI W,WANG J,et al.Factors associated with dysfunction of autogenous arteriovenous fistula in patients with maintenance hemodialysis:a retrospective study£ÛJ£Ý.Ann Palliat Med,2021,10(4):4047-4054.
£Û4£Ý¡¡DU J,KONG X,LIANG L,et al.Plasma D-dimer level and the failure of forearm autologous arteriovenous fistula in patients with end-stage renal disease£ÛJ£Ý.Ther Apher Dial,2020,24(4):400-407.
£Û5£Ý¡¡ÕÅÖ¾¼á,³Âº­Ö¦,Áõ±ó,µÈ.ѪÇå³ÉÏËάϸ°ûÉú³¤Òò×Ó23ÔÚè㶯Âö¸Æ»¯¼°¶¯¾²ÂöÄÚðüʧ¹¦ÖеÄÔ¤²â×÷ÓãÛJ£Ý.ÖйúѪҺ¾»»¯,2021,20(6):410-414.
ZHANG Z J,CHEN H Z,LIU B,et al.Serum fibroblast growth factor-23(FGF-23)level for predicting radial artery calcification and arterio-venous fistula dysfunction in hemodialysis patients£ÛJ£Ý.Chin J Blood Purif,2021,20(6):410-414.
£Û6£Ý¡¡CASARI G,RESCA E,GIORGINI A,et al.Microfragmented adipose tissue is associated with improved ex vivo performance linked to HOXB7 and b-FGF expression£ÛJ£Ý.Stem Cell Res Ther,2021,12(1):481.
£Û7£Ý¡¡NALAIRNDRAN G,HASSAN ABDUL RAZACK A,MAI C W,et al.Phosphoinositide-dependent kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated kinase 3 (SGK3) for prostate cancer cell survival£ÛJ£Ý.J Cell Mol Med,2020,24(20):12188-12198.
£Û8£Ý¡¡KIM J,KIM D,JUNG H,et al.Identification and kinetic characterization of serum- and glucocorticoid-regulated kinase inhibitors using a fluorescence polarization-based assay£ÛJ£Ý.SLAS Discov,2021,26(5):655-662.
£Û9£Ý¡¡JIANG F,LIU H,PENG F,et al.Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma£ÛJ£Ý.Cancer Biol Med,2021,18(3):21-33.
£Û10£Ý¡¡CHEN J,ZHOU M,ZENG K,et al.The risk factors of autogenous arteriovenous fistula dysfunction in maintenance hemodialysis patients and the curative effect of personalized nursing£ÛJ£Ý.Am J Transl Res,2021,13(5):5107-5116.
£Û11£Ý¡¡SPILIOPOULOS S,GIANNIKOURIS I E,KATSANOS K,et al.Volume flow assistance for optimizing outcomes of dysfunctional autologous arteriovenous fistula angioplasty:the VOLA pilot study£ÛJ£Ý.Eur Radiol,2022,32(1):368-376.
£Û12£Ý¡¡ARAGONCILLO SAUCO I,HEVIA C,MANZANO GROSSI S,et al.Effect of preoperative exercise on vascular caliber and maturation of arteriovenous fistula:the physicalfav trial,a randomized controlled study£ÛJ£Ý.J Nephrol,2021,34(3):763-771.
£Û13£Ý¡¡SEE Y P,CHO Y,PASCOE E M,et al.Predictors of arteriovenous fistula failure:a post hoc analysis of the FAVOURED study£ÛJ£Ý.Kidney360,2020,1(11):1259-1269.
£Û14£Ý¡¡KALLER R,MUREÿ AN A V,ARB A~NAÿ I E M,et al.Uncommon surgical management by AVF between the great saphenous vein and anterior tibial artery for old radiocephalic AVF failure£ÛJ£Ý.Life (Basel),2022,12(4):529.
£Û15£Ý¡¡QIAN J,YU J,ZHU X,et al.MiR-335 promotes corneal neovascularization by targeting EGFR£ÛJ£Ý.BMC Ophthalmol,2022,22(1):267.
£Û16£Ý¡¡ABE S,SATO S,AONO Y,et al.Functional analysis of human fibrocytes derived from monocytes reveals their profibrotic phenotype through paracrine effects£ÛJ£Ý.J Med Invest,2020,67(1.2):102-112.
£Û17£Ý¡¡YUAN Y F,ZHU W X,LIU T,et al.Cyclopamine functions as a suppressor of benign prostatic hyperplasia by inhibiting epithelial and stromal cell proliferation via suppression of the Hedgehog signaling pathway£ÛJ£Ý.Int J Mol Med,2020,46(1):311-319.
£Û18£Ý¡¡HUO Q,XU C,SHAO Y,et al.Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway£ÛJ£Ý.Int J Biol Sci,2021,17(2):574-588.
£Û19£Ý¡¡POKORNY D,TRUEBESTEIN L,FLEMING K D,et al.In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate£ÛJ£Ý.J Biol Chem,2021,297(2):100919.
£Û20£Ý¡¡CEBECI A N,ZOU M,BINESSA H A,et al.Mutation of SGK3,a novel regulator of renal phosphate transport,causes autosomal dominant hypophosphatemic rickets£ÛJ£Ý.J Clin Endocrinol Metab,2020,105(6):dgz260.

ÏàËÆÎÄÏ×/References:

[1]çÑ»ÆÌ©,ÎâÐÇÐÀ,ÐÁÒã,µÈ.¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×ÓÌåÍâÓÕµ¼È®¹ÇËè¼ä³äÖʸÉϸ°ûÏòÐļ¡Ñùϸ°û·Ö»¯[J].ÐÂÏçҽѧԺѧ±¨,,():000.
[2]çÑ»ÆÌ©,ÎâÐÇÐÀ,ÐÁÒã,µÈ.¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×ÓÌåÍâÓÕµ¼È®¹ÇËè¼ä³äÖʸÉϸ°ûÏòÐļ¡Ñùϸ°û·Ö»¯[J].ÐÂÏçҽѧԺѧ±¨,,():000.
[3]Íõ¡¡·å,ÕÅ¡¡ìÏ,ÀîÄÈÄÈ.¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×Ó¶ÔСÊó¹ÇËèÄÚƤϸ°ûÔöÖ³µÄ´Ù½ø×÷ÓÃ[J].ÐÂÏçҽѧԺѧ±¨,2006,23(05):475.
[4]Àîϼ.¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×ÓÖÎÁÆÈì´¯ÁÆЧ¹Û²ì[J].ÐÂÏçҽѧԺѧ±¨,2010,27(04):371.
[5]ÂíʤÀû.Ï¥¹Ç¹Ø½ÚÑ×»¼ÕßѪÇåÑ×ÐÔÒò×ÓÓëѪ¹ÜÉú³ÉÏà¹ØÒò×ӵĹØϵ[J].ÐÂÏçҽѧԺѧ±¨,2016,33(7):626.[doi:10.7683/xxyxyxb.2016.07.021]
¡¡MA Sheng-li.Relationship between serum inflammatory factors and angiogenesis related factors in patients with knee osteoarthritis[J].Journal of Xinxiang Medical University,2016,33(9):626.[doi:10.7683/xxyxyxb.2016.07.021]

¸üÐÂÈÕÆÚ/Last Update: 2023-09-05